Reaching new frontiers will require both strategic and financial planning
Pharma navigates unfriendly terrain to reach the next frontier in affordable drugs
AAM Access! 2019 makes it clear that generics have earned their seat at the table
Industry underdogs look giant challenges in the eye
White Papers: In Depth Research
Posted: Feb 08, 2017
As pharma companies look more and more to biologics for their next potential blockbusters, they must face the challenges surrounding these products' scientific complexity and sophisticated development.